Metropolitan Life Insurance Company (MetLife)’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-5,026
| Closed | -$21.1K | – | 1341 |
|
2024
Q1 | $21.1K | Hold |
5,026
| – | – | ﹤0.01% | 1834 |
|
2023
Q4 | $23.6K | Hold |
5,026
| – | – | ﹤0.01% | 1841 |
|
2023
Q3 | $15.7K | Hold |
5,026
| – | – | ﹤0.01% | 2005 |
|
2023
Q2 | $23.1K | Hold |
5,026
| – | – | ﹤0.01% | 1854 |
|
2023
Q1 | $24.9K | Sell |
5,026
-1,713
| -25% | -$8.48K | ﹤0.01% | 1768 |
|
2022
Q4 | $36.8K | Hold |
6,739
| – | – | ﹤0.01% | 1662 |
|
2022
Q3 | $43.8K | Hold |
6,739
| – | – | ﹤0.01% | 1551 |
|
2022
Q2 | $31.9K | Hold |
6,739
| – | – | ﹤0.01% | 1782 |
|
2022
Q1 | $47.1K | Sell |
6,739
-20,012
| -75% | -$140K | ﹤0.01% | 1637 |
|
2021
Q4 | $273K | Buy |
+26,751
| New | +$273K | ﹤0.01% | 1799 |
|